Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_assertion description "[Although the effect of new drugs such as poly(ADP-ribose) polymerase inhibitors are being investigated in ovarian cancer, there is still a need to develop targeted therapies-especially to tackle mutations in PI3 K pathway, RAS pathway and TP53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_assertion evidence source_evidence_literature NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_assertion SIO_000772 25473022 NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_assertion wasDerivedFrom befree-2016 NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_assertion wasGeneratedBy ECO_0000203 NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1244678.RA3aIHmS3w05d8Pg5y9TI5t_ugTJRJFgnsgOyYhXvLtkI130_provenance.